Live feed
Filing
SC 13G
SC 13G0001213900-17-008051·INTRACOASTAL CAPITAL, LLC
Schedule 13G ownership disclosure
ImmunoCellular Therapeutics, Ltd.
Security class unavailable
Event date: 2017-07-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,161,765
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-17-008051
- Form type
- SC 13G
- Filer
- INTRACOASTAL CAPITAL, LLC
- CIK
- CIK 1646799
- Filed
- Jul 31, 2017
- Reporting period
- Jul 21, 2017
- Description
- Schedule 13G beneficial ownership